SEC Stock Data Quick Answer EXAGEN INC. reported Gross Profit of $38.80 million for fiscal year 2025. EXAGEN INC. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $38.80M +17.2% 2024 $33.11M +12.4% 2023 $29.46M — Quarterly Gross Profit Quarter Ending Gross Profit YoY QoQ September 30, 2025 $10.07M +44.3% -3.1% June 30, 2025 $10.39M … Read more
Quick Answer EXAGEN INC. reported Operating Income of -$14.07 million for fiscal year 2025. EXAGEN INC. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$14.07M -3.2% 2024 -$13.64M +40.3% 2023 -$22.84M +50.4% 2022 -$46.05M -91.3% 2021 -$24.07M -58.5% 2020 -$15.19M -63.3% 2019 -$9.30M -90.6% 2018 -$4.88M — Quarterly Operating Income Quarter … Read more
Quick Answer EXAGEN INC. reported R&D Expense of $6.25 million for fiscal year 2025. EXAGEN INC. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $6.25M +16.4% 2024 $5.38M +10.5% 2023 $4.87M -50.7% 2022 $9.88M +36.5% 2021 $7.24M +102.8% 2020 $3.57M +64.0% 2019 $2.18M +2.4% 2018 $2.12M — Quarterly R&D Expense Quarter … Read more
Quick Answer EXAGEN INC. reported Stockholders Equity of $17.45 million for fiscal year 2025. EXAGEN INC. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $17.45M +82.9% 2024 $9.54M -58.0% 2023 $22.69M -46.6% 2022 $42.46M -50.0% 2021 $84.94M +103.0% 2020 $41.84M -24.8% 2019 $55.66M +149.7% 2018 -$111.97M -15.8% 2017 -$96.68M — Quarterly … Read more
Quick Answer EXAGEN INC. reported Long-Term Debt of $22.26 million for fiscal year 2025. EXAGEN INC. Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $22.26M +12.3% 2024 $19.82M +3.1% 2023 $19.23M -33.2% 2022 $28.78M +4.7% 2021 $27.48M +3.1% 2020 $26.66M +3.1% 2019 $25.85M +5.0% 2018 $24.62M — Quarterly Long-Term Debt Quarter … Read more
Quick Answer EXAGEN INC. reported Cash and Equivalents of $32.22 million for fiscal year 2025. EXAGEN INC. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $32.22M +46.2% 2024 $22.04M -39.6% 2023 $36.49M -41.5% 2022 $62.39M -37.3% 2021 $99.44M +73.1% 2020 $57.45M -20.3% 2019 $72.08M +447.6% 2018 $13.16M — Quarterly … Read more
Quick Answer EXAGEN INC. reported Total Assets of $58.02 million for fiscal year 2025. EXAGEN INC. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $58.02M +29.8% 2024 $44.69M -21.5% 2023 $56.94M -34.0% 2022 $86.22M -30.2% 2021 $123.44M +57.5% 2020 $78.38M -11.3% 2019 $88.31M +205.7% 2018 $28.89M — Quarterly Total Assets Quarter … Read more
Quick Answer EXAGEN INC. reported Diluted EPS of $0.93 per share (loss) for fiscal year 2025. EXAGEN INC. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$0.93 -12.0% 2024 -$0.83 +38.1% 2023 -$1.34 +51.6% 2022 -$2.77 -64.9% 2021 -$1.68 -27.3% 2020 -$1.32 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY … Read more
Quick Answer EXAGEN INC. reported Net Income of -$19.95 million for fiscal year 2025. EXAGEN INC. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$19.95M -32.0% 2024 -$15.12M +36.2% 2023 -$23.69M +50.0% 2022 -$47.39M -76.5% 2021 -$26.85M -60.9% 2020 -$16.69M -38.6% 2019 -$12.04M -50.2% 2018 -$8.01M — Quarterly Net Income Quarter … Read more
Quick Answer EXAGEN INC. reported Revenue (ASC 606) of $66.58 million for fiscal year 2025. EXAGEN INC. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $66.58M +19.7% 2024 $55.64M +5.9% 2023 $52.55M +15.3% 2022 $45.56M -5.7% 2021 $48.30M +15.1% 2020 $41.98M +3.9% 2019 $40.39M +24.5% 2018 $32.44M — Quarterly … Read more